The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.

Candace A. Beck(University of Colorado Health), Dean P. Edwards(Baylor College of Medicine), Steven K. Nordeen(University of Colorado Health), Nancy L. Weigel(Baylor College of Medicine), M L Moyer(University of Colorado Health)
Proceedings of the National Academy of Sciences
May 15, 1993
Cited by 210


Related Papers